S

Active Director Director DIN 08923692
DIN 08923692 First appointment Oct 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Shakuntla

Data last updated:

Shakuntla is a Director at Qantas Biopharma Private Limited (since 2020). The company operates in Healthcare. Qantas Biopharma Private Limited reported revenue of ₹7.5 Lakh (FY 2024).

DIN 08923692
Primary Designation Director
Industry Healthcare
First Appointment 17 Oct 2020
Oldest Company Age 6 yrs
Largest company Qantas Biopharma Private Limited · ₹7.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Qantas Biopharma Private Limited U73100HR2020PTC090217
Director17 Oct 20202020₹7.5 Lakh (FY 2024)Active

Board colleagues of Shakuntla

NameDINCompanyDesignation
Ritu08923691Qantas Biopharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Qantas Biopharma Private Limited
Premium access

Shareholding and investment profile for Shakuntla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shakuntla

Shakuntla currently holds 1 directorship: Qantas Biopharma Private Limited (Director, since 17 Oct 2020, revenue ₹7.5 Lakh (FY 2024)).

Shakuntla was first appointed on 17 Oct 2020 as Director at Qantas Biopharma Private Limited.

The current boards of Shakuntla's companies include Ritu (Qantas Biopharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available